Cargando…

Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation

BACKGROUND: Ablative therapy is a recommended treatment for hepatocellular carcinoma (HCC) not only for its effective eradication of tumors, but also for its induction of host immunity. However, the high 5-year recurrence rate after ablation underlines the poor understanding of the antitumor immunit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Chaoran, Zhao, Yan, Liu, Guihai, Li, Kang, Qin, Ling, Zhang, Yuewei, Sun, Jianping, Wang, Qi, Ma, Liang, Zhao, Peng, Sun, Yu, Guo, Dandan, Yuan, Chunwang, Dong, Tao, Zhang, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813410/ https://www.ncbi.nlm.nih.gov/pubmed/36618423 http://dx.doi.org/10.3389/fimmu.2022.982578

Ejemplares similares

Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma
por: Guo, Dandan, et al.
Publicado: (2023)

A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies
por: Wang, Qi, et al.
Publicado: (2019)

T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell
por: Liu, Sai, et al.
Publicado: (2019)

Genomic DNA methylation profiling indicates immune response following thermal ablation treatment for HBV-associated hepatocellular carcinoma
por: Zhao, Yanan, et al.
Publicado: (2020)

Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages
por: Zang, Chaoran, et al.
Publicado: (2021)

Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Percutaneous thermal ablation combined with transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma: Efficacy and survival
por: Sun, Yu, et al.
Publicado: (2022)

Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy
por: Qiao, Wenying, et al.
Publicado: (2022)

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
por: Sajid, Muhammad, et al.
Publicado: (2022)

Non‐transplantable recurrence after percutaneous thermal ablation of ≤3‐cm HCC: Predictors and implications for treatment allocation
por: Gozzo, Cecilia, et al.
Publicado: (2022)

The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study
por: Wang, Qi, et al.
Publicado: (2021)

New techniques: a roadmap for the development of HCC immunotherapy
por: Jiang, Dizhi, et al.
Publicado: (2023)

Percutaneous Thermal Ablation Therapy of Hepatocellular Carcinoma (HCC): Microwave Ablation (MWA) versus Laser-Induced Thermotherapy (LITT)
por: Adwan, Hamzah, et al.
Publicado: (2022)

A Nomogram Prediction of Length of Hospital Stay in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study
por: Li, Kang, et al.
Publicado: (2021)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

Tumor Regression in HCC Patient with Portal Vein Tumor Thrombosis after Intraportal Radiofrequency Thermal Ablation
por: Mizandari, Malkhaz, et al.
Publicado: (2016)

Factors Associated with Recurrence of Varicose Veins after Thermal Ablation: Results of The Recurrent Veins after Thermal Ablation Study
por: Bush, R. G., et al.
Publicado: (2014)

Decidual macrophages derived NO downregulates PD-L1 in trophoblasts leading to decreased Treg cells in recurrent miscarriage
por: Zhang, Yonghong, et al.
Publicado: (2023)

Ablative Therapy in Non-HCC Liver Malignancy
por: Robinson, Tyler P., et al.
Publicado: (2023)

Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Prediction of Therapeutic Efficacy of Anti-PD-1 Antibodies in Advanced HCC Patients
por: Yuan, Guosheng, et al.
Publicado: (2021)

The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy
por: Wang, Qi, et al.
Publicado: (2022)

Predicting hepatocellular carcinoma early recurrence after ablation based on magnetic resonance imaging radiomics nomogram
por: Yang, Xiaozhen, et al.
Publicado: (2022)

A CpG Methylation Signature as a Potential Marker for Early Diagnosis of Hepatocellular Carcinoma From HBV-Related Liver Disease Using Multiplex Bisulfite Sequencing
por: Li, Kang, et al.
Publicado: (2021)

T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis via integrating single-cell RNA-seq and bulk RNA-sequencing
por: Chi, Hao, et al.
Publicado: (2023)

The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
por: Zhang, Lilong, et al.
Publicado: (2022)

Preoperative Gadoxetic Acid-Enhanced MRI Based Nomogram Improves Prediction of Early HCC Recurrence After Ablation Therapy
por: Hu, Chengguang, et al.
Publicado: (2021)

Potential biomarkers for predicting immune response and outcomes in lung cancer patients undergoing thermal ablation
por: Sang, Jing, et al.
Publicado: (2023)

Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts
por: Yuan, Guosheng, et al.
Publicado: (2022)

Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram
por: Yuan, Chunwang, et al.
Publicado: (2019)

Comprehensive analysis of the clinical significance, immune infiltration, and biological role of MARCH ligases in HCC
por: Cao, Jun, et al.
Publicado: (2022)

CAXII inhibitors: Potential sensitizers for immune checkpoint inhibitors in HCC treatment
por: Han, Rui, et al.
Publicado: (2023)

Immunogenic change after percutaneous microwave ablation in pulmonary malignancies: Variation in immune cell subsets and cytokines in peripheral blood
por: Zhang, Liang, et al.
Publicado: (2022)

The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis
por: Batal, Ibrahim, et al.
Publicado: (2023)

Case Report: Recurrent Autoimmune Hypoglycemia Induced by Non-Hypoglycemic Medications
por: Zhu, Qiuping, et al.
Publicado: (2022)

Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma
por: Zhang, Dandan, et al.
Publicado: (2023)

Establishment of a lncRNA-Based Prognostic Gene Signature Associated With Altered Immune Responses in HCC
por: Li, Xiawei, et al.
Publicado: (2022)

Efficacy of re-resection versus radiofrequency ablation for recurrent Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma (HCC) after resection for primary HCC
por: Yin, Xieling, et al.
Publicado: (2019)

The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation
por: Li, Kang, et al.
Publicado: (2020)

Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC
por: Shi, Jihang, et al.
Publicado: (2023)

Combining WGCNA and machine learning to construct basement membrane-related gene index helps to predict the prognosis and tumor microenvironment of HCC patients and verifies the carcinogenesis of key gene CTSA
por: Sun, Weijie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a24c1lenhihrd4jecgeuhjltpf